PreComb Therapeutics

PreComb Therapeutics Develops 3D Drug Testing Technology for In Vitro Cancer Diagnosis to Improve Cancer Management. The company's technology is based on automated analysis of micro-tumors, enabling clinical institutions to integrate the testing on-site at hospitals. The test can directly functionally evaluate multiple cancer drugs, drug combinations, and drug concentrations on patient-derived micro-tumors to maximize treatment efficacy, allowing doctors to select effective cancer treatments for patients.